greeksoup/ stock research

Universal Health Services (UHS) FY2021 results: revenue $12.6 billion, up 9.4% on the year

Universal Health Services Inc. (UHS) reported revenue of $12.6 billion for fiscal 2021, the year ended 31 December 2021, up 9.4% on the year before. Net income was $992 million, up 5.0%, and diluted earnings per share $11.82. The figures are the company's own, from the 10-K it filed with the SEC on 24 February 2022.

Revenue
$12.6 billion
+9.4% on the year
FY2014FY2021
Operating margin
10.8%
11.8% a year earlier
FY2014FY2021
Net income
$992 million
+5.0% on the year
FY2014FY2021
Diluted EPS
$11.82
+7.6% on the year
FY2014FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue12,64211,55911,378+9.4%
Operating income1,3631,3581,216+0.3%
Operating margin10.8%11.8%10.7%
Interest expense83.7106163-21.3%
Pre-tax income1,2931,2521,066+3.3%
Income tax306299239+2.1%
Effective tax rate23.6%23.9%22.4%
Net income992944815+5.0%
Net margin7.8%8.2%7.2%
Diluted EPS$11.82$10.99$9.13+7.6%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow8842,3601,438-62.6%
Capital expenditure856731634+17.0%
Free cash flow28.01,629804-98.3%
Free cash flow margin0.2%14.1%7.1%
Cash from investing-914-803-688
Cash from financing-1,069-385-845
Depreciation and amortisation533510490+4.5%
Share-based compensation73.765.869.4+11.9%
Buybacks1,221207771+490.6%
Dividends paid65.917.353.0+279.9%
Dividend per share$0.80n/a$0.60
Diluted shares, weighted84m86m89m-2.2%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity6,0906,3175,504-3.6%
Non-controlling interest10384.874.8+21.9%
Redeemable equity5.14.64.3+12.0%
Debt4,1903,8563,984+8.7%
Operating lease liabilities305278270+9.5%
Finance lease liabilities76.650.816.4+50.6%
Other liabilities2,3242,8851,814-19.4%
Total liabilities and equity13,09413,47711,668-2.8%
Fixed assets5,8745,3735,017+9.3%
Goodwill3,9633,8833,870+2.1%
Intangible assets81.082.683.7-1.9%
Cash and equivalents1151,22461.3-90.6%
Receivables1,7471,7291,561+1.0%
Other assets1,3141,1851,076+10.9%
Total assets13,09413,47711,668-2.8%

10-K for the year ended 31 December 2021, filed 24 February 2022: the filing.